This is the authors' abstract. We don't add key points for this paper.
To characterize the efficacy and safety profiles of AXS-07 in the acute treatment of migraine headache by pooling two phase 3 clinical studies.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Tepper et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: